Epstein Barr Virus Infection

Infectious mononucleosis in childhood, especially in adolescence, appeared to increase risk for an MS diagnosis, independent of shared familial factors, according to results of a population-based cohort study published in JAMA Network Open.

Deficiencies in the CARMIL2 gene can lead to a variety of immunodeficiency complications, including cutaneous and respiratory allergies, necessitating clinician attention and further research, according to a study published in Allergy.

More than 80% of patients who responded to therapy with tabelecleucel for Epstein-Barr virus-driven post-transplant lymphoproliferative disease remained alive 2 years after initial treatment, study results showed.

A novel allogeneic Epstein-Barr virus-targeted T-cell immunotherapy in early development was well-tolerated and led to sustained disability improvements in patients with progressive forms of MS, researchers reported at MSVirtual2020.